Abstract:OBJECTIVE:Protein phosphatase 2A (PP2A) is a target for cisplatin, which is a widely used platinum drug to treat various cancer, including ovarian cancer. However, to date, the exact role of PP2A in chemoresistance to cisplatin-centered ovarian cancer therapy is not clear. METHODS AND MATERIALS:To analyze the function of PP2A in cisplatin-resistant ovarian cancer cells, we derived A2780/cisplatin (CDDP), which is resistant to cisplatin, from A2780 cell line. Western blotting was used to detect the expression of PP2A, autophagy, and apoptosis markers. RESULTS:The expression of PP2A catalytic subunit, (PP2Ac) was reduced in A2780/CDDP as well as in cisplatin-resistant patients' tissues compared with A2780 and cisplatin-sensitive patients. In the A2780 cells, cisplatin induced both apoptosis and autophagy. Interestingly, however, the autophagy inhibitor 3-methyladenine increased the cell death induced by diamindichloridoplatin (DDP), which suggested the protective function of autophagy in DDP-induced cell death. Knocking down of PP2A promoted autophagy but suppressed DDP-induced apoptosis and cell death. In contrast, overexpression of PP2Ac or reinduction of the activity of PP2A by FTY720 decreased autophagy but increased cell death induced by DDP. Our experiments demonstrated that apoptosis suppressed by the knocking down of PP2Ac can be reversed by the administration of 3-methyladenine. The elevated accumulation of microtubule-associated protein 1 light chain 3-II and the decline of the autophagy substrate p62 were also observed in PP2Ac-small interfering RNA transfected cells. However, overexpression of PP2Ac suppressed the accumulation of microtubule-associated protein 1 light chain 3-II and restored p62. CONCLUSIONS:Taken together, our results showed that protective autophagy regulated by PP2Ac is at least part of the mechanism to how certain ovarian cancers are resistant to cisplatin. Prospective studies are necessary to determine the detailed mechanism of how PP2Ac regulates autophagy in chemoresistant patients.

PP2A mediates apoptosis or autophagic cell death in multiple myeloma cell lines.

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

DAB2IP Coordinates Both PI3K-Akt and ASK1 Pathways for Cell Survival and Apoptosis

High Expression of BCAT1 Sensitizes AML Cells to PARP Inhibitor by Suppressing DNA Damage Response

Protein Phosphatase 2a (Pp2a) Is Essential For Cd8+T Cell Mediated Anti-Tumor Immunity

Protein Phosphatase 2A Suppresses Bcl2’s Antiapoptotic Function by Regulating Bcl2-p53 Interaction

PP2A-Mediated Anticancer Therapy.

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

PHLPP Sensitizes Multiple Myeloma Cells to Bortezomib Through Regulating LAMP2.

Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis

Protein Phosphatase-2A is a Target of Epigallocatechin-3-Gallate and Modulates P53-Bak Apoptotic Pathway

PP2A Inhibitors Trigger Apoptosis of Pancreatic Cancer PANC-1 Cells Through Nuclear Factor-Κb-dependent Pathway

Cancerous Inhibitor Of Protein Phosphatase 2a Determines Bortezomib-Induced Apoptosis In Leukemia Cells

PP2A Inhibitors Induce Apoptosis in Pancreatic Cancer Cell Line PANC-1 Through Persistent Phosphorylation of IKKα and Sustained Activation of the NF-κB Pathway.

Protein phosphatase 2A regulates cytotoxicity and drug resistance by dephosphorylating AHR and MDR1

Betulinic Acid Inhibits Autophagic Flux and Induces Apoptosis in Human Multiple Myeloma Cells in Vitro

Protein Phosphatase 2A Inhibitors Activate Extrinsic Apoptosis in Pancreatic Cancer Cells Through Nuclear Factor-Κb Dependent Pathway

PP2A negatively regulates NK cell T-bet expression and anti-tumor effector function

Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.

The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells

Targeting Autophagy Augments in Vitro and in Vivo Antimyeloma Activity of DNA-damaging Chemotherapy.